Randomized Placebo Controlled Phase 2 Trial of Bekinda (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Condition:   Irritable Bowel Syndrome With DiarrheaInterventions:   Drug: BEKINDA;   Drug: PlaceboSponsor:   RedHill Biopharma LimitedRecruiting - verified May 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials